GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (XCNQ:TIUM.U) » Definitions » Pretax Margin %

Cansortium (XCNQ:TIUM.U) Pretax Margin % : 31.48% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cansortium Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cansortium's Pre-Tax Income for the three months ended in Jun. 2024 was $8.6 Mil. Cansortium's Revenue for the three months ended in Jun. 2024 was $27.3 Mil. Therefore, Cansortium's pretax margin for the quarter that ended in Jun. 2024 was 31.48%.

The historical rank and industry rank for Cansortium's Pretax Margin % or its related term are showing as below:

XCNQ:TIUM.U' s Pretax Margin % Range Over the Past 10 Years
Min: -172.09   Med: -23.95   Max: 7.24
Current: 7.24


XCNQ:TIUM.U's Pretax Margin % is ranked better than
56.15% of 1008 companies
in the Drug Manufacturers industry
Industry Median: 4.785 vs XCNQ:TIUM.U: 7.24

Cansortium Pretax Margin % Historical Data

The historical data trend for Cansortium's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Pretax Margin % Chart

Cansortium Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial -172.09 -58.03 -17.36 -30.53 -9.41

Cansortium Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.43 11.08 -17.34 2.07 31.48

Competitive Comparison of Cansortium's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cansortium's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cansortium's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cansortium's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Cansortium's Pretax Margin % falls into.



Cansortium Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Cansortium's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-9.156/97.29
=-9.41 %

Cansortium's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=8.583/27.269
=31.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cansortium  (XCNQ:TIUM.U) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Cansortium Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Cansortium's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cansortium Business Description

Traded in Other Exchanges
Address
82 North East 26th Street, Suite 110, Miami, FL, USA, 33137
Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

No Headlines